NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Denis Migliorini@MiglioriniDenis
Neuro Oncologist, Brain tumor Immunologist, passion about immune cell engineering
March 19

Join us for the upcoming French Society of Neurology conference in Paris. The line up is impressive!
Extremely honored to present updates on our research alongside pioneers in neuro oncology and neurosurgery with Roger Stupp, Hugues Duffau, Martin Van den Bent among others

Oncology Division - Geneva University Hospital@DOncologie
Oct.4, 2022

Join us for Prof. Roger Stupp's Lecture tomorrow! Pr Stupp is a pioneer in innovative drug development for brain tumors, 2 FDA approved therapies are based on his research for #Glioblastoma. He will be hosted by Pr Migliorini Denis

https://twitter.com/DOncologie/status/1537316021639471104/photo/1
Martin van den Bent@MartinvdenBent

Critical review of the report on the DCvax-L trial: the trial did not meet its prospectively defined endpoint and post-hoc analyses with poorly selected external controls do not replace a proper prospective trial

Critical review of the report on the DCvax-L trial: the trial did not meet its prospectively defined endpoint and post-hoc analyses with poorly selected external controls do not replace a proper prospective trial https://t.co/3kJnHYW4P6

— Martin van den Bent (@MartinvdenBent) December 23, 2022